Dyne Therapeutics, Inc. ($DYN)
Kerr Douglas โ Head of R&D and CMO
Shares
12,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Kerr Douglas |
|---|---|
| Title | Head of R&D and CMO |
| Transaction Date | Oct 20, 2026 |
| Expiration Date | Oct 19, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Oct 22, 2026 |
| Shares Purchased | 12,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 12,000 |
| Derivative | Derivative |
| Accession Number | 0001814189-26-000007 |
| Document | View SEC Filing |